Invention Grant
- Patent Title: Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
-
Application No.: US14199402Application Date: 2014-03-06
-
Publication No.: US09226931B2Publication Date: 2016-01-05
- Inventor: Gurpreet Ahluwalia , Frederick C. Beddingfield , Sydney G. Edwards , Scott M. Whitcup
- Applicant: Allergan, Inc.
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Lorenz Siddiqi
- Main IPC: A61K8/00
- IPC: A61K8/00 ; A61K31/5575 ; A61K31/165 ; A61K31/506 ; A61K31/438 ; A61K8/42 ; A61Q7/00 ; A61K31/557 ; A61K31/558 ; A61K8/49 ; A61Q1/10 ; A61K8/63 ; A61K9/00
Abstract:
The present invention is directed to compositions and methods for the treatment of post-chemotherapeutic hypotrichosis. More specifically, the present invention is directed to the use of compositions comprising bimatoprost for the treatment of post-chemotherapeutic hypotrichosis which may be applied before, during and after receiving chemotherapeutic treatment.
Public/Granted literature
Information query
